CVS Group PLC (DE:4C9)
FRANKFURT:4C9
4C9 Analyst Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
4C9 Stock 12 Month Forecast
Average Price Target
€19.30
▲(33.13% Upside)
| Highest Price Target€23.12 | Average Price Target€19.30 | Lowest Price Target€15.49 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Barclays
€15.49
Hold
6.82%
Upside
Reiterated
05/14/26
RBC Capital
€21.96
Buy
51.46%
Upside
Reiterated
03/04/26
Jefferies
€14.45→€16.41
Hold
13.20%
Upside
Reiterated
10/29/25
12:35 AM 2025 UK | Healthcare Services CVS Group | HOLD CVSG LN | 1,326.00p | 1,420.00p | % to +7% Key Takes from JEF "Back-to-School" Fireside Chat We hosted CEO Richard Fairman as part of our C-Suite Back-to-School series. Key takeaways: 1) CMA proposed remedies could potentially affect independents disproportionately; 2) Q4 LFL momentum continued into the new year, but still below MT range; 3) Pricing will meaningfully contribute to MT ambition; 4) UK M&A activity to pick up, but valuation is key. CMA-proposed remedies could potentially affect independents disproportionately: Management stated that as CMA remedies cover the entire market, independents could find execution more burdensome, especially around real ‑time price publication & electronic prescriptions.
Deutsche Bank
€17.34→€19.65
Buy
35.52%
Upside
Reiterated
10/21/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
€15.49
Hold
6.82%
Upside
Reiterated
05/14/26
RBC Capital
€21.96
Buy
51.46%
Upside
Reiterated
03/04/26
Jefferies
€14.45→€16.41
Hold
13.20%
Upside
Reiterated
10/29/25
12:35 AM 2025 UK | Healthcare Services CVS Group | HOLD CVSG LN | 1,326.00p | 1,420.00p | % to +7% Key Takes from JEF "Back-to-School" Fireside Chat We hosted CEO Richard Fairman as part of our C-Suite Back-to-School series. Key takeaways: 1) CMA proposed remedies could potentially affect independents disproportionately; 2) Q4 LFL momentum continued into the new year, but still below MT range; 3) Pricing will meaningfully contribute to MT ambition; 4) UK M&A activity to pick up, but valuation is key. CMA-proposed remedies could potentially affect independents disproportionately: Management stated that as CMA remedies cover the entire market, independents could find execution more burdensome, especially around real ‑time price publication & electronic prescriptions.
Deutsche Bank
€17.34→€19.65
Buy
35.52%
Upside
Reiterated
10/21/25
Best Analysts Covering CVS Group plc
3 Months
Success Rate
11/16 ratings generated profit
Average Return
+7.62%
Copying Charles Weston's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +7.62% per trade.
1 Year
Success Rate
5/16 ratings generated profit
Average Return
-5.54%
Copying Charles Weston's trades and holding each position for 1 Year would result in 31.25% of your transactions generating a profit, with an average return of -5.54% per trade.
2 Years
Success Rate
6/16 ratings generated profit
Average Return
-3.69%
Copying Charles Weston's trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of -3.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
4C9 Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
1
1
Buy
0
1
1
1
0
Hold
0
1
2
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
2
3
5
3
Each month's total comprises the sum of three months' worth of ratings.
4C9 Financial Forecast
4C9 Stock Forecast FAQ
What is DE:4C9’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Group PLC’s 12-month average price target is 19.30.
What is DE:4C9’s upside potential, based on the analysts’ average price target?
CVS Group PLC has 33.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CVS Group PLC a Buy, Sell or Hold?
CVS Group PLC has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is CVS Group PLC’s share price target?
The average share price target for CVS Group PLC is 19.30. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €23.12 ,and the lowest forecast is €15.49. The average share price target represents 33.13% Increase from the current price of €14.5.
The highest analyst share price target is €23.12 ,and the lowest forecast is €15.49. The average share price target represents 33.13% Increase from the current price of €14.5.
What do analysts say about CVS Group PLC?
CVS Group PLC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of CVS Group PLC?
To buy shares of DE:4C9, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.